These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 16824807

  • 1. Is insulin resistance atherogenic? A review of the evidence.
    Ferrannini E, Iozzo P.
    Atheroscler Suppl; 2006 Aug; 7(4):5-10. PubMed ID: 16824807
    [Abstract] [Full Text] [Related]

  • 2. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E, DeFronzo RA.
    Diabetes Metab Res Rev; 2006 Aug; 22(6):423-36. PubMed ID: 16506274
    [Abstract] [Full Text] [Related]

  • 3. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O.
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [Abstract] [Full Text] [Related]

  • 4. [Insulin resistance and cardiovascular complications].
    Janka HU.
    Wien Klin Wochenschr; 1994 Mar; 106(24):758-62. PubMed ID: 7846894
    [Abstract] [Full Text] [Related]

  • 5. Insulin-resistance syndrome and cardiovascular complications of non-insulin-dependent diabetes mellitus.
    Fontbonne A.
    Diabetes Metab; 1996 Oct; 22(5):305-13. PubMed ID: 8896991
    [Abstract] [Full Text] [Related]

  • 6. Endothelial dysfunction in insulin resistance and type 2 diabetes.
    Jansson PA.
    J Intern Med; 2007 Aug; 262(2):173-83. PubMed ID: 17645585
    [Abstract] [Full Text] [Related]

  • 7. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
    Nathanson D, Nyström T.
    Mol Cell Endocrinol; 2009 Jan 15; 297(1-2):112-26. PubMed ID: 19038307
    [Abstract] [Full Text] [Related]

  • 8. The relation of insulin resistance syndromes to risk of cardiovascular disease.
    Nesto RW.
    Rev Cardiovasc Med; 2003 Jan 15; 4 Suppl 6():S11-8. PubMed ID: 14668699
    [Abstract] [Full Text] [Related]

  • 9. Impaired endothelial function and insulin action in first-degree relatives of patients with type 2 diabetes mellitus.
    Sonne MP, Højbjerre L, Alibegovic AA, Vaag A, Stallknecht B, Dela F.
    Metabolism; 2009 Jan 15; 58(1):93-101. PubMed ID: 19059536
    [Abstract] [Full Text] [Related]

  • 10. Diabetes and cardiovascular disease: explaining the relationship.
    Punthakee Z, Werstuck GH, Gerstein HC.
    Rev Cardiovasc Med; 2007 Jan 15; 8(3):145-53. PubMed ID: 17938614
    [Abstract] [Full Text] [Related]

  • 11. Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease.
    Tenenbaum A, Adler Y, Boyko V, Tenenbaum H, Fisman EZ, Tanne D, Lapidot M, Schwammenthal E, Feinberg MS, Matas Z, Motro M, Behar S.
    Am Heart J; 2007 Apr 15; 153(4):559-65. PubMed ID: 17383294
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
    Ahmed I, Goldstein BJ.
    Mt Sinai J Med; 2006 Sep 15; 73(5):759-68. PubMed ID: 17008936
    [Abstract] [Full Text] [Related]

  • 13. Insulin resistance and hypertension. Patients in double jeopardy for cardiovascular disease.
    McLaughlin T, Reaven G.
    Geriatrics; 2000 Jun 15; 55(6):28-32, 35. PubMed ID: 10872343
    [Abstract] [Full Text] [Related]

  • 14. Endothelial function varies according to insulin resistance disease type.
    Beckman JA, Goldfine AB, Dunaif A, Gerhard-Herman M, Creager MA.
    Diabetes Care; 2007 May 15; 30(5):1226-32. PubMed ID: 17261751
    [Abstract] [Full Text] [Related]

  • 15. Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study.
    van Sloten TT, Henry RM, Dekker JM, Nijpels G, Unger T, Schram MT, Stehouwer CD.
    Hypertension; 2014 Dec 15; 64(6):1299-305. PubMed ID: 25225211
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.
    Rask-Madsen C, King GL.
    Nat Clin Pract Endocrinol Metab; 2007 Jan 15; 3(1):46-56. PubMed ID: 17179929
    [Abstract] [Full Text] [Related]

  • 17. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB, Wilson PW.
    Diabetes Care; 2007 May 15; 30(5):1219-25. PubMed ID: 17259468
    [Abstract] [Full Text] [Related]

  • 18. [Hyperinsulinemia and cardiovascular risk].
    Brunelli C, Spallarossa P, Cordera R, Caponnetto S.
    Cardiologia; 1994 Dec 15; 39(12 Suppl 1):163-8. PubMed ID: 7634261
    [Abstract] [Full Text] [Related]

  • 19. Rationale for the use of insulin sensitizers to prevent cardiovascular events in type 2 diabetes mellitus.
    Fonseca VA.
    Am J Med; 2007 Sep 15; 120(9 Suppl 2):S18-25. PubMed ID: 17826042
    [Abstract] [Full Text] [Related]

  • 20. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
    Hemmingsen B, Lund SS, Vaag A.
    Ugeskr Laeger; 2009 May 04; 171(19):1598-602. PubMed ID: 19419642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.